Structure

Physi-Chem Properties

Molecular Weight:  436.19
Volume:  453.039
LogP:  6.297
LogD:  3.865
LogS:  -2.838
# Rotatable Bonds:  4
TPSA:  85.22
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.647
Synthetic Accessibility Score:  4.016
Fsp3:  0.346
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.797
MDCK Permeability:  1.5742440155008808e-05
Pgp-inhibitor:  0.99
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.053
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.004

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.026
Plasma Protein Binding (PPB):  99.73467254638672%
Volume Distribution (VD):  0.479
Pgp-substrate:  2.5737767219543457%

ADMET: Metabolism

CYP1A2-inhibitor:  0.191
CYP1A2-substrate:  0.484
CYP2C19-inhibitor:  0.602
CYP2C19-substrate:  0.411
CYP2C9-inhibitor:  0.894
CYP2C9-substrate:  0.826
CYP2D6-inhibitor:  0.866
CYP2D6-substrate:  0.184
CYP3A4-inhibitor:  0.639
CYP3A4-substrate:  0.252

ADMET: Excretion

Clearance (CL):  1.297
Half-life (T1/2):  0.048

ADMET: Toxicity

hERG Blockers:  0.039
Human Hepatotoxicity (H-HT):  0.857
Drug-inuced Liver Injury (DILI):  0.935
AMES Toxicity:  0.051
Rat Oral Acute Toxicity:  0.906
Maximum Recommended Daily Dose:  0.643
Skin Sensitization:  0.866
Carcinogencity:  0.418
Eye Corrosion:  0.003
Eye Irritation:  0.137
Respiratory Toxicity:  0.371

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC236756

Natural Product ID:  NPC236756
Common Name*:   3-Methoxyminimiflorin
IUPAC Name:   (7R,8R)-5-hydroxy-8-(2-hydroxyphenyl)-7-methoxy-2,2-dimethyl-10-(3-methylbut-2-enyl)-7,8-dihydropyrano[3,2-g]chromen-6-one
Synonyms:   3-Methoxyminimiflorin
Standard InCHIKey:  ZQNJQIORXQNFHJ-RPBOFIJWSA-N
Standard InCHI:  InChI=1S/C26H28O6/c1-14(2)10-11-17-22-16(12-13-26(3,4)32-22)20(28)19-21(29)25(30-5)24(31-23(17)19)15-8-6-7-9-18(15)27/h6-10,12-13,24-25,27-28H,11H2,1-5H3/t24-,25+/m1/s1
SMILES:  CC(=CCc1c2c(C=CC(C)(C)O2)c(c2C(=O)[C@@H]([C@@H](c3ccccc3O)Oc12)OC)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL521624
PubChem CID:   10433154
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0000337] Flavans
          • [CHEMONTID:0003642] 8-prenylated flavans
            • [CHEMONTID:0003508] 8-prenylated flavanones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24957 Bucida buceras Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[12542360]
NPO28183 Cymbopogon flexuosus Species Poaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28183 Cymbopogon flexuosus Species Poaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28353 Schizanthus pinnatus Species Solanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28235 Heimia montana Species Lythraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11029 Bessera tenuiflora Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28564 Pterorhachis zenkeri Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28411 Hedysarum setigerum Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO24957 Bucida buceras Species Combretaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28183 Cymbopogon flexuosus Species Poaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28736 Wedelia paludosa Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28113 Oria flava n.a. n.a. n.a. n.a. n.a. n.a. Database[UNPD]
NPO14464 Oxalis triangularis Species Oxalidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 6.5 ug.mL-1 PMID[569180]
NPT81 Cell Line A549 Homo sapiens IC50 = 7.6 ug.mL-1 PMID[569180]
NPT309 Cell Line 1A9 Homo sapiens IC50 = 7.8 ug.mL-1 PMID[569180]
NPT180 Cell Line HCT-8 Homo sapiens IC50 = 7.2 ug.mL-1 PMID[569180]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 7.0 ug.mL-1 PMID[569180]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 8.4 ug.mL-1 PMID[569180]
NPT147 Cell Line SK-MEL-2 Homo sapiens IC50 = 7.8 ug.mL-1 PMID[569180]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 7.0 ug.mL-1 PMID[569180]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 8.6 ug.mL-1 PMID[569180]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC236756 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC311579
0.9797 High Similarity NPC48579
0.9797 High Similarity NPC304207
0.9797 High Similarity NPC207809
0.9797 High Similarity NPC217706
0.9797 High Similarity NPC259710
0.973 High Similarity NPC180301
0.973 High Similarity NPC248793
0.9664 High Similarity NPC111341
0.9664 High Similarity NPC476169
0.9664 High Similarity NPC304745
0.9658 High Similarity NPC296869
0.9597 High Similarity NPC223701
0.9597 High Similarity NPC268193
0.9597 High Similarity NPC472583
0.9597 High Similarity NPC7989
0.9595 High Similarity NPC262038
0.9595 High Similarity NPC254412
0.9595 High Similarity NPC319910
0.9595 High Similarity NPC278476
0.9595 High Similarity NPC262039
0.9589 High Similarity NPC296998
0.9589 High Similarity NPC473077
0.953 High Similarity NPC216035
0.953 High Similarity NPC35567
0.953 High Similarity NPC56232
0.953 High Similarity NPC150123
0.953 High Similarity NPC475790
0.953 High Similarity NPC138288
0.953 High Similarity NPC244583
0.953 High Similarity NPC210597
0.953 High Similarity NPC171651
0.953 High Similarity NPC243171
0.953 High Similarity NPC217149
0.953 High Similarity NPC161881
0.953 High Similarity NPC10807
0.9527 High Similarity NPC105136
0.9527 High Similarity NPC472633
0.9527 High Similarity NPC61258
0.9524 High Similarity NPC244407
0.9521 High Similarity NPC195621
0.9521 High Similarity NPC54577
0.9521 High Similarity NPC83357
0.9521 High Similarity NPC5820
0.9521 High Similarity NPC124729
0.9521 High Similarity NPC176229
0.9521 High Similarity NPC178343
0.9521 High Similarity NPC301276
0.9521 High Similarity NPC142405
0.9521 High Similarity NPC214774
0.9521 High Similarity NPC88964
0.9521 High Similarity NPC267375
0.9521 High Similarity NPC20488
0.9521 High Similarity NPC312973
0.9521 High Similarity NPC475052
0.9521 High Similarity NPC306488
0.9521 High Similarity NPC67805
0.9521 High Similarity NPC246948
0.9521 High Similarity NPC111786
0.9521 High Similarity NPC470647
0.947 High Similarity NPC215917
0.947 High Similarity NPC20530
0.947 High Similarity NPC10754
0.9467 High Similarity NPC293286
0.9467 High Similarity NPC88983
0.9467 High Similarity NPC469405
0.9467 High Similarity NPC20907
0.9467 High Similarity NPC244250
0.9467 High Similarity NPC100134
0.9467 High Similarity NPC209760
0.9463 High Similarity NPC471675
0.9463 High Similarity NPC289774
0.9463 High Similarity NPC471677
0.9463 High Similarity NPC477897
0.9463 High Similarity NPC474021
0.9463 High Similarity NPC472636
0.9463 High Similarity NPC474023
0.9463 High Similarity NPC263384
0.9463 High Similarity NPC471676
0.9463 High Similarity NPC209846
0.9463 High Similarity NPC472422
0.9463 High Similarity NPC328740
0.9463 High Similarity NPC244577
0.9463 High Similarity NPC472420
0.9459 High Similarity NPC470461
0.9459 High Similarity NPC5173
0.9456 High Similarity NPC166757
0.9456 High Similarity NPC472918
0.9456 High Similarity NPC23728
0.9456 High Similarity NPC283234
0.9456 High Similarity NPC14001
0.9456 High Similarity NPC110303
0.9452 High Similarity NPC216538
0.9452 High Similarity NPC273538
0.9408 High Similarity NPC284820
0.9408 High Similarity NPC210048
0.9408 High Similarity NPC282390
0.9408 High Similarity NPC281137
0.9408 High Similarity NPC473272
0.9404 High Similarity NPC470681
0.9404 High Similarity NPC471116
0.9404 High Similarity NPC477958
0.94 High Similarity NPC327269
0.94 High Similarity NPC473996
0.94 High Similarity NPC31627
0.94 High Similarity NPC476238
0.9396 High Similarity NPC471115
0.9396 High Similarity NPC29777
0.9392 High Similarity NPC132592
0.9392 High Similarity NPC161191
0.9392 High Similarity NPC160821
0.9392 High Similarity NPC470460
0.9388 High Similarity NPC472629
0.9388 High Similarity NPC470458
0.9388 High Similarity NPC220418
0.9384 High Similarity NPC24821
0.9384 High Similarity NPC293053
0.9384 High Similarity NPC158874
0.9384 High Similarity NPC316816
0.9384 High Similarity NPC219915
0.9384 High Similarity NPC212932
0.9384 High Similarity NPC214166
0.9384 High Similarity NPC478086
0.9384 High Similarity NPC9117
0.9384 High Similarity NPC190637
0.9355 High Similarity NPC66087
0.9355 High Similarity NPC472625
0.9355 High Similarity NPC179198
0.9355 High Similarity NPC183672
0.9355 High Similarity NPC278419
0.9346 High Similarity NPC264932
0.9346 High Similarity NPC311574
0.9342 High Similarity NPC146636
0.9338 High Similarity NPC203080
0.9338 High Similarity NPC326592
0.9338 High Similarity NPC109594
0.9338 High Similarity NPC112701
0.9333 High Similarity NPC471229
0.9333 High Similarity NPC472580
0.9333 High Similarity NPC295650
0.9329 High Similarity NPC477941
0.9329 High Similarity NPC277032
0.9329 High Similarity NPC473016
0.9329 High Similarity NPC472628
0.9324 High Similarity NPC85773
0.9324 High Similarity NPC97716
0.9324 High Similarity NPC44721
0.9324 High Similarity NPC472627
0.9324 High Similarity NPC40086
0.9324 High Similarity NPC122828
0.9324 High Similarity NPC201731
0.9324 High Similarity NPC237635
0.9324 High Similarity NPC24673
0.9324 High Similarity NPC3779
0.9324 High Similarity NPC476182
0.9324 High Similarity NPC176869
0.9324 High Similarity NPC104406
0.9324 High Similarity NPC211466
0.9324 High Similarity NPC79469
0.932 High Similarity NPC326500
0.932 High Similarity NPC131568
0.932 High Similarity NPC209040
0.932 High Similarity NPC224714
0.932 High Similarity NPC470890
0.932 High Similarity NPC87486
0.932 High Similarity NPC131579
0.932 High Similarity NPC319752
0.932 High Similarity NPC124780
0.9315 High Similarity NPC228504
0.9315 High Similarity NPC10937
0.9315 High Similarity NPC220998
0.9315 High Similarity NPC182852
0.9315 High Similarity NPC107572
0.9315 High Similarity NPC473042
0.9315 High Similarity NPC37496
0.9315 High Similarity NPC78
0.9315 High Similarity NPC64915
0.9315 High Similarity NPC227579
0.9315 High Similarity NPC265040
0.9315 High Similarity NPC76338
0.9315 High Similarity NPC166482
0.9315 High Similarity NPC223500
0.9315 High Similarity NPC1089
0.9315 High Similarity NPC166934
0.9315 High Similarity NPC161506
0.9315 High Similarity NPC40833
0.9315 High Similarity NPC200694
0.9315 High Similarity NPC66515
0.9315 High Similarity NPC32739
0.9315 High Similarity NPC324436
0.9315 High Similarity NPC328164
0.9315 High Similarity NPC177354
0.9315 High Similarity NPC306829
0.9315 High Similarity NPC167624
0.9315 High Similarity NPC76372
0.9315 High Similarity NPC125855
0.9315 High Similarity NPC194432
0.9315 High Similarity NPC296917
0.9315 High Similarity NPC148757
0.9315 High Similarity NPC324134

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC236756 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9452 High Similarity NPD4378 Clinical (unspecified phase)
0.9281 High Similarity NPD7075 Discontinued
0.9267 High Similarity NPD4380 Phase 2
0.9211 High Similarity NPD7096 Clinical (unspecified phase)
0.9119 High Similarity NPD7804 Clinical (unspecified phase)
0.9085 High Similarity NPD2393 Clinical (unspecified phase)
0.902 High Similarity NPD6801 Discontinued
0.8973 High Similarity NPD1552 Clinical (unspecified phase)
0.8973 High Similarity NPD1550 Clinical (unspecified phase)
0.8933 High Similarity NPD7410 Clinical (unspecified phase)
0.8912 High Similarity NPD1549 Phase 2
0.891 High Similarity NPD4381 Clinical (unspecified phase)
0.8903 High Similarity NPD8443 Clinical (unspecified phase)
0.8896 High Similarity NPD1934 Approved
0.8812 High Similarity NPD6168 Clinical (unspecified phase)
0.8812 High Similarity NPD6167 Clinical (unspecified phase)
0.8812 High Similarity NPD6166 Phase 2
0.8776 High Similarity NPD2796 Approved
0.8742 High Similarity NPD6799 Approved
0.871 High Similarity NPD7411 Suspended
0.8707 High Similarity NPD1510 Phase 2
0.8662 High Similarity NPD3817 Phase 2
0.8659 High Similarity NPD6797 Phase 2
0.8627 High Similarity NPD1512 Approved
0.8608 High Similarity NPD3882 Suspended
0.8606 High Similarity NPD7251 Discontinued
0.8599 High Similarity NPD2801 Approved
0.8571 High Similarity NPD5403 Approved
0.8554 High Similarity NPD7808 Phase 3
0.8526 High Similarity NPD6599 Discontinued
0.8509 High Similarity NPD6959 Discontinued
0.8497 Intermediate Similarity NPD1511 Approved
0.8481 Intermediate Similarity NPD7819 Suspended
0.8447 Intermediate Similarity NPD5494 Approved
0.8443 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8442 Intermediate Similarity NPD5401 Approved
0.8435 Intermediate Similarity NPD1240 Approved
0.8428 Intermediate Similarity NPD5402 Approved
0.8424 Intermediate Similarity NPD7054 Approved
0.8373 Intermediate Similarity NPD7472 Approved
0.8373 Intermediate Similarity NPD7074 Phase 3
0.8354 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8322 Intermediate Similarity NPD1607 Approved
0.8261 Intermediate Similarity NPD7768 Phase 2
0.8261 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8253 Intermediate Similarity NPD3818 Discontinued
0.8182 Intermediate Similarity NPD3750 Approved
0.8166 Intermediate Similarity NPD6559 Discontinued
0.8117 Intermediate Similarity NPD2800 Approved
0.8117 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8098 Intermediate Similarity NPD3749 Approved
0.8095 Intermediate Similarity NPD5844 Phase 1
0.8061 Intermediate Similarity NPD1247 Approved
0.8049 Intermediate Similarity NPD919 Approved
0.8012 Intermediate Similarity NPD6232 Discontinued
0.8 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD920 Approved
0.7978 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7976 Intermediate Similarity NPD7473 Discontinued
0.7955 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7922 Intermediate Similarity NPD1551 Phase 2
0.7922 Intermediate Similarity NPD2935 Discontinued
0.7907 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD1243 Approved
0.7865 Intermediate Similarity NPD4360 Phase 2
0.7865 Intermediate Similarity NPD4363 Phase 3
0.7862 Intermediate Similarity NPD2532 Approved
0.7862 Intermediate Similarity NPD2534 Approved
0.7862 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD2533 Approved
0.7857 Intermediate Similarity NPD3748 Approved
0.7848 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7843 Intermediate Similarity NPD6651 Approved
0.7834 Intermediate Similarity NPD4628 Phase 3
0.7824 Intermediate Similarity NPD3751 Discontinued
0.7815 Intermediate Similarity NPD2313 Discontinued
0.78 Intermediate Similarity NPD4908 Phase 1
0.7798 Intermediate Similarity NPD3787 Discontinued
0.7791 Intermediate Similarity NPD5953 Discontinued
0.7778 Intermediate Similarity NPD7286 Phase 2
0.7778 Intermediate Similarity NPD5124 Phase 1
0.7778 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD7033 Discontinued
0.7742 Intermediate Similarity NPD2799 Discontinued
0.7722 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD6798 Discontinued
0.7692 Intermediate Similarity NPD6099 Approved
0.7692 Intermediate Similarity NPD6100 Approved
0.7688 Intermediate Similarity NPD7584 Approved
0.7687 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD3926 Phase 2
0.7643 Intermediate Similarity NPD2344 Approved
0.7602 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD1613 Approved
0.7597 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD1465 Phase 2
0.7578 Intermediate Similarity NPD7390 Discontinued
0.7576 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD1610 Phase 2
0.7561 Intermediate Similarity NPD3226 Approved
0.7554 Intermediate Similarity NPD6777 Approved
0.7554 Intermediate Similarity NPD6780 Approved
0.7554 Intermediate Similarity NPD6776 Approved
0.7554 Intermediate Similarity NPD6779 Approved
0.7554 Intermediate Similarity NPD6778 Approved
0.7554 Intermediate Similarity NPD6781 Approved
0.7554 Intermediate Similarity NPD6782 Approved
0.7548 Intermediate Similarity NPD6355 Discontinued
0.7534 Intermediate Similarity NPD1548 Phase 1
0.7532 Intermediate Similarity NPD2346 Discontinued
0.7532 Intermediate Similarity NPD6233 Phase 2
0.7527 Intermediate Similarity NPD7435 Discontinued
0.7516 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2403 Approved
0.7484 Intermediate Similarity NPD2424 Discontinued
0.7484 Intermediate Similarity NPD943 Approved
0.7483 Intermediate Similarity NPD1203 Approved
0.7468 Intermediate Similarity NPD3268 Approved
0.7458 Intermediate Similarity NPD8312 Approved
0.7458 Intermediate Similarity NPD8313 Approved
0.7455 Intermediate Similarity NPD7458 Discontinued
0.7453 Intermediate Similarity NPD3887 Approved
0.7453 Intermediate Similarity NPD2309 Approved
0.7451 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD6832 Phase 2
0.7434 Intermediate Similarity NPD2798 Approved
0.7433 Intermediate Similarity NPD7698 Approved
0.7433 Intermediate Similarity NPD7697 Approved
0.7433 Intermediate Similarity NPD7696 Phase 3
0.7432 Intermediate Similarity NPD4361 Phase 2
0.7432 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD8150 Discontinued
0.743 Intermediate Similarity NPD8434 Phase 2
0.7423 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD4308 Phase 3
0.7403 Intermediate Similarity NPD4625 Phase 3
0.7394 Intermediate Similarity NPD7870 Phase 2
0.7394 Intermediate Similarity NPD7871 Phase 2
0.7386 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD5711 Approved
0.7384 Intermediate Similarity NPD5710 Approved
0.7381 Intermediate Similarity NPD8455 Phase 2
0.7378 Intermediate Similarity NPD5049 Phase 3
0.7374 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD4060 Phase 1
0.7368 Intermediate Similarity NPD2797 Approved
0.7366 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD2354 Approved
0.7346 Intermediate Similarity NPD6190 Approved
0.7341 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD422 Phase 1
0.7333 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD1652 Phase 2
0.7325 Intermediate Similarity NPD1933 Approved
0.7321 Intermediate Similarity NPD6844 Discontinued
0.7303 Intermediate Similarity NPD3225 Approved
0.7292 Intermediate Similarity NPD7874 Approved
0.7292 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD3027 Phase 3
0.7288 Intermediate Similarity NPD3823 Discontinued
0.7285 Intermediate Similarity NPD9717 Approved
0.7283 Intermediate Similarity NPD6534 Approved
0.7283 Intermediate Similarity NPD6535 Approved
0.7277 Intermediate Similarity NPD7701 Phase 2
0.7277 Intermediate Similarity NPD7585 Approved
0.7262 Intermediate Similarity NPD5890 Approved
0.7262 Intermediate Similarity NPD5889 Approved
0.7253 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD4288 Approved
0.7232 Intermediate Similarity NPD1729 Discontinued
0.7225 Intermediate Similarity NPD7583 Approved
0.7222 Intermediate Similarity NPD2654 Approved
0.7215 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD447 Suspended
0.7215 Intermediate Similarity NPD230 Phase 1
0.7205 Intermediate Similarity NPD2353 Approved
0.7205 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD1471 Phase 3
0.7202 Intermediate Similarity NPD6585 Discontinued
0.7197 Intermediate Similarity NPD4062 Phase 3
0.7188 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD7229 Phase 3
0.7166 Intermediate Similarity NPD7699 Phase 2
0.7166 Intermediate Similarity NPD7700 Phase 2
0.7165 Intermediate Similarity NPD7783 Phase 2
0.7165 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD7801 Approved
0.7161 Intermediate Similarity NPD2861 Phase 2
0.7158 Intermediate Similarity NPD4287 Approved
0.7152 Intermediate Similarity NPD4307 Phase 2
0.7152 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD7213 Phase 3
0.7152 Intermediate Similarity NPD7212 Phase 2
0.715 Intermediate Similarity NPD8151 Discontinued
0.7143 Intermediate Similarity NPD3266 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data